TITLE

Multiple Symmetric Lipomatosis

AUTHOR(S)
Haap, Michael; Siewecke, Cornelia; Thamer, Claus; Machann, Jürgen; Schick, Fritz; Häring, Hans-U.; Szeimies, Rolf M.; Stumvoll, Michael
PUB. DATE
March 2004
SOURCE
Diabetes Care;Mar2004, Vol. 27 Issue 3, p794
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the effects of obesity on patients with type 2 diabetes. Assessment on the resistance of the body from insulin treatment; Causes of metabolic disorder; Measurement the blood pressure of the patients.
ACCESSION #
12421024

 

Related Articles

  • Stressed out about obesity and insulin resistance. de Luca, Carl; Olefsky, Jerrold M. // Nature Medicine;Jan2006, Vol. 12 Issue 1, p41 

    The article reports on the link between the stress pathway of the endoplasmic reticulum (ER) to obesity-related chronic inflammation underlying insulin resistance. One of the characteristic feature of type 2 diabetes is the insulin resistance and the pathophysiological defect in the metabolic...

  • Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes. Viardot, A.; Heilbronn, L. K.; Herzog, H.; Gregersen, S.; Campbell, L. V. // International Journal of Obesity;Jun2008, Vol. 32 Issue 6, p943 

    Objective:Gut-derived hormone peptide YY (PYY) is low in subjects with obesity and type 2 diabetes (T2D). However, it is unknown whether this is a primary defect or a consequence of metabolic disturbances. In this study, we aimed to assess whether low fasting and postprandial PYY secretion is an...

  • Clinical: Metabolic syndrome diagnosis is a matter of urgency. Abraham, Ralph // GP: General Practitioner;6/17/2005, p42 

    The article presents a discussion on metabolic disorders. The metabolic syndrome comprises of: diabetes or impaired glucose tolerance, abdominal obesity, dyslipidaemia and hypertension. Insulin resistance remains the core defect of type-2 diabetes. Although intense management to normoglycaemia...

  • Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location. Foster, Michelle T.; Pagliassotti, Michael J. // Adipocyte;Oct-Dec2012, Vol. 1 Issue 4, p192 

    Increased visceral adiposity is a risk factor for metabolic disorders such as dyslipidemia, hypertension, insulin resistance and type 2 diabetes, whereas peripheral (subcutaneous) obesity is not. Though the specific mechanisms which contribute to these adipose depot differences are unknown,...

  • A Mathematical Model of the Human Metabolic System and Metabolic Flexibility. Pearson, T.; Wattis, J.; King, J.; MacDonald, I.; Mazzatti, D. // Bulletin of Mathematical Biology;Sep2014, Vol. 76 Issue 9, p2091 

    In healthy subjects some tissues in the human body display metabolic flexibility, by this we mean the ability for the tissue to switch its fuel source between predominantly carbohydrates in the postprandial state and predominantly fats in the fasted state. Many of the pathways involved with...

  • Getting away from glucose: fanning the flames of obesity-induced inflammation. Shoelson, Steven E.; Goldfine, Allison B. // Nature Medicine;Apr2009, Vol. 15 Issue 4, p373 

    The article focuses on the link of obesity to inflammation. It states that inflammation has substantial role in the pathogenesis of disorders varying from insulin resistance and type 2 diabetes to fatty liver and cardiovascular disease. Overviews of various studies conducted that relates obesity...

  • Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet-Fed Mice. Jiang, Changtao; Qu, Aijuan; Matsubara, Tsutomu; Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana; Shah, Yatrik M.; Gonzalez, Frank J. // Diabetes;Oct2011, Vol. 60 Issue 10, p2484 

    OBJECTIVE-Obesity, insulin resistance, and type 2 diabetes form a tightly correlated cluster of metabolic disorders in which adipose is one of the rst affected tissues. The role of hypoxia and hypoxia-inducible factor 1 (HIF1) in the development of high-fat diet (HFD)-induced obesity and insulin...

  • Phenotypic Type 2 Diabetes in Obese Youth. Tfayli, Hala; Bacha, Fida; Gungor, Neslihan; Arslanian, Silva // Diabetes;March2009, Vol. 58 Issue 3, p738 

    OBJECTIVE--Some obese youth with a clinical diagnosis of type 2 diabetes have evidence of islet cell autoimmunity with positive autoantibodies. In this study, we investigated the differences in insulin sensitivity and secretion between autoantibody-negative (Ab-) and -positive (Ab+) youth with...

  • The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders. Benetti, Elisa; Chiazza, Fausto; Patel, Nimesh S. A.; Collino, Massimo // Mediators of Inflammation;2013, Vol. 2013, p1 

    The combination of obesity and type 2 diabetes is a serious health problem, which is projected to afflict 300 million people worldwide by 2020. Both clinical and translational laboratory studies have demonstrated that chronic inflammation is associated with obesity and obesity-related conditions...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics